ArticleArchives of rheumatology2023

Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations.

Joy Artin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.